Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 4:40 p.m.

    📋 SEAGEN INC. (SGEN) - Financial Results

    Filing Date: 2022-07-28

    Accepted: 2022-07-28 16:05:40

    Event Type: Financial Results

    Event Details:

    Seagen Inc (was acquised by Pfizer Inc. (NYSE: PFE) on 14/12/2023) (SGEN) Reports Q3 2022 Financial Results Seagen Inc (was acquised by Pfizer Inc. (NYSE: PFE) on 14/12/2023) (SGEN) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 106100
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 1850322

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Selling General Administrative 165.13K 394.48K $-229.35K -58.14%
    Loss From Operations -89.60K -266.16K $176.56K +66.34%
    Net Loss -84.58K -84.58K $0.00 +0.00%
    Net Loss Per Share -0.47 -0.47 $0.00 +0.00%
    Assets Other Assets 1.78M 1.56M $220.45K +14.14%
    Revenue 39.11K 36.30K $2.81K +7.75%
    Selling, General & Administrative 220.26K 165.13K $55.13K +33.39%
    Loss from Operations -133.11K -89.60K $-43.51K -48.56%
    Net Loss -134.83K -134.83K $0.00 +0.00%
    Other Assets 1.78M 1.56M $220.45K +14.14%
    Accounts Payable 608.52K 608.52K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Seagen Inc (was acquised by Pfizer Inc. (NYSE: PFE) on 14/12/2023)
    • CIK: 0001060736
    • Ticker Symbol: SGEN
    • Period End Date: 2022-07-28
    • Document Type: 8-K

Search

News categories